PTGR1 and neoplasm: Our previous studies demonstrate that LP-284 doesn’t require PTGR1 for activation, but retains strong antitumor activities in the NCI-60 human tumor cell line panel (Zhou et al., 2022 Society of Hematologic Oncology conference abstract # MCL319).